BioNTech Gets In On ADC Action With DualityBio Licensing Deal

 
• By Alaric DeArment
  
BioNTech and DualityBio signed a licensing deal for two antibody-drug conjugate candidates • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business